288 related articles for article (PubMed ID: 32034715)
1. STAT Signaling in Glioma Cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
[TBL] [Abstract][Full Text] [Related]
2. STAT signaling in glioma cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2013; 986():189-208. PubMed ID: 22879070
[TBL] [Abstract][Full Text] [Related]
3. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
4. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
5. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
7. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
Swiatek-Machado K; Mieczkowski J; Ellert-Miklaszewska A; Swierk P; Fokt I; Szymanski S; Skora S; Szeja W; Grynkiewicz G; Lesyng B; Priebe W; Kaminska B
Cancer Biol Ther; 2012 Jun; 13(8):657-70. PubMed ID: 22555804
[TBL] [Abstract][Full Text] [Related]
8. Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
Hua L; Wang G; Wang Z; Fu J; Fang Z; Zhuang T; Zhao L; Zong Z; Ye C; Liu H; Zhu Y; Yu R
J Neurooncol; 2019 May; 143(1):35-47. PubMed ID: 30993511
[TBL] [Abstract][Full Text] [Related]
9. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
10. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
11. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
13. [Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].
Espert L; Dusanter-Fourt I; Chelbi-Alix MK
Bull Cancer; 2005 Oct; 92(10):845-57. PubMed ID: 16266868
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
15. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.
Wang G; Qian P; Jackson FR; Qian G; Wu G
Int J Biochem Cell Biol; 2008; 40(3):461-70. PubMed ID: 17920330
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
17. STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells.
Adach-Kilon A; Swiatek-Machado K; Kaminska B; Dabrowski M
J Cell Biochem; 2011 Dec; 112(12):3685-94. PubMed ID: 21815198
[TBL] [Abstract][Full Text] [Related]
19. STATs in oncogenesis.
Bowman T; Garcia R; Turkson J; Jove R
Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]